Simple Summary Positron emission tomography/computed tomography (PET/CT) has an
increasingly relevant role in the management of oncological patients. It consists of the …

Simple Summary Positron emission tomography/computed tomography (PET/CT) with
prostate-specific membrane antigen (PSMA)-targeting radiopharmaceuticals is a relatively …

Simple Summary Immuno-Oncology (IO) based combinations are now the standard of care
for frontline advanced clear cell renal cell carcinoma. Despite the unprecedented durable …

Introduction In the last decade, two new radionuclide-based therapies, 223Radichloride and
radioligand therapy (RLT) targeting prostate-specific membrane antigen (PSMA), have been …

Simple Summary Current imaging techniques do not reliably distinguish renal cell
carcinoma from other renal diseases. This review summarizes recent advances in other …

Radioligand therapy (RLT) agents are demonstrating a crucial role in the clinical approach
to aggressive malignancies such as metastatic castrate-resistant prostate cancer (m-CRPC) …

Background: prostate-specific membrane antigen (PSMA) ligand PET has been recently
incorporated into international guidelines for several different indications in prostate cancer …

Introduction Triple-negative breast cancer (TNBC) is a subtype of breast cancer
characterized by the absence of estrogen, progesterone, and HER2 receptors. It …

Simple Summary In this paper we systematically evaluate the evidence regarding the role of
[68Ga] PSMA PET/CT for clinical suspicions of prostate cancer in patients with or without …

Background The clinical relevance of circulating tumor cell-white blood cell (CTC-WBC)
clusters in cancer prognosis is a subject of ongoing debate. This study aims to unravel their …